Arovella Therapeutics Ltd
F:E4NA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arovella Therapeutics Ltd
F:E4NA
|
AU |
|
Fidea Holdings Co Ltd
F:5F9
|
JP |
|
Medistim ASA
OSE:MEDI
|
NO |
|
M
|
Masco Corp
XMUN:MSQ
|
US |
|
W
|
Wise PLC
LSE:WISE
|
UK |
|
A
|
Avrot Industries Ltd
TASE:AVRT
|
IL |
|
Aquarius AI Inc
OTC:GOOLF
|
CA |
|
F
|
Franco-Nevada Corp
F:3FO
|
CA |
|
Star Equity Holdings Inc
NASDAQ:STRR
|
US |
|
R
|
Raghuvansh Agrofarms Ltd
BSE:538921
|
IN |
|
DBS Group Holdings Ltd
SGX:D05
|
SG |
|
B
|
BuildDirect.com Technologies Inc
XTSX:BILD
|
CA |
|
Endesa SA
F:ENA
|
ES |
|
Toyo Tire Corp
F:TYR
|
JP |
|
R
|
Radcom Ltd
F:RAM
|
IL |
|
A
|
Autoneum Holding AG
XBER:AN9
|
CH |
|
D
|
Dong A Eltek Co Ltd
KOSDAQ:088130
|
KR |
|
Aecon Group Inc
TSX:ARE
|
CA |
Bankruptcy Probability
Arovella Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arovella Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Arovella Therapeutics Ltd
ASX:ALA
|
72.1m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
374.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
244.5B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arovella Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arovella Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
